"Neuraminidase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992)
| Descriptor ID |
D009439
|
| MeSH Number(s) |
D08.811.277.450.692
|
| Concept/Terms |
Neuraminidase- Neuraminidase
- Exo-alpha-Sialidase
- Exo alpha Sialidase
- Sialidase
- N-Acylneuraminate Glycohydrolases
- Glycohydrolases, N-Acylneuraminate
- N Acylneuraminate Glycohydrolases
- Oligosaccharide Sialidase
- Sialidase, Oligosaccharide
|
Below are MeSH descriptors whose meaning is more general than "Neuraminidase".
Below are MeSH descriptors whose meaning is more specific than "Neuraminidase".
This graph shows the total number of publications written about "Neuraminidase" by people in this website by year, and whether "Neuraminidase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 3 | 0 | 3 |
| 2000 | 2 | 0 | 2 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 2 | 1 | 3 |
| 2022 | 0 | 2 | 2 |
| 2024 | 1 | 0 | 1 |
| 2025 | 2 | 0 | 2 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuraminidase" by people in Profiles.
-
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions. J Clin Invest. 2026 Mar 16; 136(6).
-
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site. J Clin Invest. 2025 Dec 01; 135(23).
-
Sialidase fusion protein protects against influenza infection in a cigarette smoke-induced model of COPD. Mucosal Immunol. 2025 Apr; 18(2):467-480.
-
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface. Immunity. 2024 06 11; 57(6):1413-1427.e9.
-
Immunological Correlates of Prevention of the Onset of Seasonal H3N2 Influenza. J Infect Dis. 2022 11 11; 226(10):1800-1808.
-
Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment. Clin Infect Dis. 2022 02 11; 74(3):532-540.
-
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice. Cell Host Microbe. 2019 12 11; 26(6):715-728.e8.
-
Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies. Cell Host Microbe. 2019 12 11; 26(6):729-738.e4.
-
Antibody Determinants of Influenza Immunity. J Infect Dis. 2019 04 08; 219(Suppl_1):S21-S29.
-
Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB/c mice-based experimental setting. Acta Trop. 2016 Jul; 159:211-8.